On Monday, Shares of Array Biopharma Inc (NASDAQ:ARRY), lost -3.18% to $4.26. Array BioPharma and Pierre Fabre, declared a partnership to globally develop and commercialize Array’s late-stage novel ...
Read more
0
ARRY